BDBM355669 (1R,3S,5R)-2-[2-(3-Acetyl- pyrazolo[3,4-c]pyridin-1-yl)- acetyl]-2-aza-bicyclo[3.1.0] hexane-3-carboxylic acid [2-(3,4- dimethyl-phenyl)-cyclopropyl]- amide (mixture of 4 diastereomers)::US9815819, 34

SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NC2CC2c2ccc(C)c(C)c2)c2cnccc12

InChI Key InChIKey=SJIJYQMSZNZJHL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 355669   

TargetComplement factor D(Human)
Novartis

US Patent
LigandPNGBDBM355669(US9815819, 34 | (1R,3S,5R)-2-[2-(3-Acetyl- pyrazol...)
Affinity DataIC50: 112nMAssay Description:Method 1: Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2019
Entry Details
US Patent